Customer experience in pharma: Getting the journey rightAs part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, Share XCustomer experience in pharma: Getting the journey righthttps://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/
UK leaders: Takeda’s Jon NealIn the first of a new series where we talk to GMs of UK pharma divisions, managing director Share XUK leaders: Takeda’s Jon Nealhttps://pharmaphorum.com/views-analysis-market-access/uk-leaders-takeda-jon-neal/
Is Tecfidera’s patent win a pyrrhic victory for Biogen?Shares in Biogen jumped last week after the company successfully defended its blockbuster MS drug Tecfidera from a Share XIs Tecfidera’s patent win a pyrrhic victory for Biogen?https://pharmaphorum.com/views-analysis-sales-marketing/tecfideras-patent-pyrrhic-victory-biogen/
What HCPs think about pharmaFor a long time, I have been observing how healthcare professionals (HCPs) are talking about the pharmaceutical industry Share XWhat HCPs think about pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/what-hcps-think-about-pharma/
5 big challenges for pharmaceutical marketers (and their agencies)For the patient demanding access to the latest medicine or the healthcare professional desperate to be able to Share X5 big challenges for pharmaceutical marketers (and their agencies)https://pharmaphorum.com/whitepapers/5-big-challenges-for-pharmaceutical-marketers-and-their-agencies/
5 years of biosimilars in the US: what have we learned?Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients Share X5 years of biosimilars in the US: what have we learned?https://pharmaphorum.com/views-analysis-market-access/5-years-of-biosimilars-in-the-us-what-have-we-learned/
How cell and gene therapies are transforming pharma deal-makingAfter decades of clinical research targeting development of more “personalised” medicines, the biotechnology sector is now starting to Share XHow cell and gene therapies are transforming pharma deal-makinghttps://pharmaphorum.com/r-d/views-analysis-r-d/how-cell-and-gene-therapies-are-transforming-pharma-deal-making/
How pharma companies can uncover the insights hidden in their contentFrom multichannel distribution to customer engagement to creative collaboration and beyond, the pharmaceutical industry is evolving the way Share XHow pharma companies can uncover the insights hidden in their contenthttps://pharmaphorum.com/whitepapers/how-pharma-companies-can-uncover-the-insights-hidden-in-their-content/
Simplicity, practicality and accessibility – primary care physicians’ clinical guideline needsNew clinical practice guidelines emerge at such a speed that it is all but impossible for primary care Share XSimplicity, practicality and accessibility – primary care physicians’ clinical guideline needshttps://pharmaphorum.com/views-and-analysis/simplicity-practicality-and-accessibility-primary-care-physicians-clinical-guideline-needs/
